Obicetrapib (TA-8995, DEZ-001) sodium is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib sodium potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib sodium can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD)[1].
Molecular Weight:
744.58
CAS Number:
[866399-88-4]
Formula:
C32H30F9N4NaO5
Target:
Apolipoprotein,CETP,LDLR,LPL Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
